When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?
Before NovemberKalshiSettled No42.7K contracts traded
No
Settled Nov 1, 2026
Opening and final price only · ring: settled No (0%), not a trade
What moved it
The largest moves on the record and what Langbot heard or read just before each one. Timing, not cause.
Langbot has the opening and final price for this market, not the path between them.
The rules
Kalshi's rules, as the venue wrote them.
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes.
The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility.
Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
- Ticker
- KXFDAANNOUNCE-BPC-26NOV01
- Closes
- Nov 1, 2026
- Category
- Science and technology
Test an idea on this market
Open it in the Langbot app to see the market brief, set alerts on its phrases and test a strategy on the events Langbot has recorded.
Test an idea on this market